Oncology Health-outcomes Liaison

Eli Lilly Eli Lilly · Pharma · United States · Remote

The Health Outcomes Liaison (HOL) serves as the medical and HEOR interface between Lilly and U.S. population-based decision makers (PBDMs) including payers, health systems, research institutions, and policy makers. The HOL role provides answers to customer questions with clinical evidence, HEOR, and RWE to support formulary access and pathways/guidelines decisions impacting millions of patients. The HOL is acutely attuned to therapeutic evidence gaps, understands environmental trends, and anticipates stakeholder evidence needs. The HOL also works cross-functionally to provide external insights to influence strategy- especially the HEOR research agenda.

What you'd actually do

  1. Independently cultivate and manage relationships with PBDMs, acting as the primary point of contact and collaborating closely with other field roles to ensure a cohesive and aligned approach to stakeholder engagement
  2. Proactively deliver and leverage scientific and value evidence and education (e.g., trial data, RWE, HEOR including observational research, comparative effectiveness, and pharmacoeconomic data) to build and sustain engaging, long-term relationships with PBDMs, ensuring their needs are met across the portfolio
  3. Synthesize, communicate, and translate complex information packages and/or data into transparent, relevant, objective, and actionable evidence, fostering trust and long-term engagement with PBDMs by addressing their strategic needs and supporting informed decision-making related to formulary access and pathways / guideline decisions across portfolio
  4. Develop and execute medical/scientific and value strategy collaborating with internal and field-based medical and commercial partners to deliver exceptional customer experiences
  5. Provide deep medical /value expertise tailored to the needs of PBDMs including opportunities for clinical optimization or collaboration on medical topics

Skills

Required

  • deep knowledge of clinical, analytic, environmental, and account-level considerations
  • knowledge of therapeutic drug classes, clinical/disease state information, Pharmacoeconomics/health outcomes, formulary management, technology assessment/value frameworks, quality measures, health policy

Nice to have

  • experience in health economic and outcomes research (HEOR)
  • experience in real-world evidence (RWE)
  • experience in drug development
  • experience in health technology assessment
  • experience in payer access
  • experience in clinical decision making